Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| KUN 2003-2911 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Dutch Cancer Society | OTHER |
The purpose of this study is to determine whether sulindac and VSL#3 - inulin, either combined or alone, are effective in treating or preventing adenoma development in the ileal anal pouch in patients with familial adenomatous polyposis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sulindac (drug) | Drug | |||
| VSL#3 (probiotic) | Drug | |||
| Inulin (probiotic) | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Pouch mucosal proliferation index at 0, 1 and 2 months | ||
| Pouch mucosal apoptosis index at 0, 1 and 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Pouch mucosal Glutathione S transferases activity and isoenzyme levels at 0, 1 and 2 months | ||
| Faecal genotoxicity at 0, 1 and 2 months | ||
| Faecal cytotoxicity at 0, 1 and 2 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pieter Friederich, MD | Contact | 00-31-24-3614760 | P.Friederich@mdl.umcn.nl | |
| Fokko M Nagengast, PhD | Contact | 00-31-24-3614760 | F.Nagengast@mdl.umcn.nl |
| Name | Affiliation | Role |
|---|---|---|
| Fokko M Nagengast, PhD | Radboud University Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Radboud University Nijmegen Medical Centre | Recruiting | Nijmegen | 6533DD | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011125 | Adenomatous Polyposis Coli |
| ID | Term |
|---|---|
| D018256 | Adenomatous Polyps |
| D000236 | Adenoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009386 | Neoplastic Syndromes, Hereditary |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D044483 | Intestinal Polyposis |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
| ID | Term |
|---|---|
| D013467 | Sulindac |
| D004364 | Pharmaceutical Preparations |
| D019936 | Probiotics |
| D007444 | Inulin |
| ID | Term |
|---|---|
| D007192 | Indenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D011083 | Polycyclic Compounds |
| D019587 | Dietary Supplements |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |
| D013213 | Starch |
| D005936 | Glucans |
| D001704 | Biopolymers |
| D011108 | Polymers |
| D046911 | Macromolecular Substances |
| D004040 | Dietary Carbohydrates |
| D002241 | Carbohydrates |
| D005630 | Fructans |
| D011134 | Polysaccharides |
Not provided
Not provided